Companies  » Health Care
 

Syngene IPO subscribed nearly 32 times

Biocon's contract research services arm, Syngene, passed the test of its Initial Public Offer of equity with flying colours

Torrent Pharma hits new lifetime high on strong Q1 results

28 Jul 2015

The stock rallied 9% to Rs 1,520 after the company posted a 75% Y-o-Y rise in consolidated net profit at Rs 449 crore in the June quarter.

Teva pays $40.5 bn for Allergan's generics arm, dumping Mylan

28 Jul 2015

Teva will pay $33.75 billion in cash and $6.75 billion worth of shares

EU-ban will impact $1 bn pharma exports from India: Pharmexcil

27 Jul 2015

Drugs made and sold directly by Indian firms make up 30% of this value, the rest comes from products sourced by global generic players from

Aurobindo Pharma gets USFDA approval for Esmolol Hydrochloride injection

27 Jul 2015

Aurobindo Pharma Limited today announced that the company has received final approvals from the US Food and Drug Administration(USFDA) to ...

EU ban on GVK-tested drugs from August 21

27 Jul 2015

The 700-odd products that underwent clinical studies here include those from six Indian firms

Correction shaves off Rs 60,600 cr m-cap of top seven cos

26 Jul 2015

Seven of the top 10 most valued Indian companies saw a combined erosion of Rs 60,600 crore in market valuation last week on account of ...

Lupin acquires specialty portfolio from German company

25 Jul 2015

Temmler Pharma has a specialty portfolio of 13 products including key Central Nervous System (CNS) products

Cipla to pay $26-mn upfront for 51% in Ugandan firm

25 Jul 2015

In May, Cipla had inked a pact with Quality Chemicals to acquire majority stake in it for a total consideration of over Rs 190 cr

Biocon eyes US market for psoriasis drug post US-Cuba thaw

24 Jul 2015

It developed Itolizumab, which it jointly developed with Cuba's Center of Molecular Immunology, for India, China and Cuban markets

Biocon gains on good Q1 results

24 Jul 2015

The stock was up 4% at Rs 475 after the company reported 23% YoY growth in consolidated net profit at Rs 126 crore in the June quarter.

Lupin acquires US generics firm GAVIS for $880 mn

24 Jul 2015

Deal marks the largest acquisition by an Indian pharma company in the US

Lupin June quarter net drops 16%

24 Jul 2015

Net profit stood at Rs 525 crore against Rs 624.7 crore last year

Biocon's Q1 FY16 net up 23% at Rs 126 cr

24 Jul 2015

Revenue up 15% at Rs 857 crore

Today's picks- 23 July 2015

23 Jul 2015

Nifty, Bank Nifty, Dr Reddy's, Tata Power, Maruti Suzuki

Lupin's Q1 hit on multiple counts

23 Jul 2015

Slow approval rate for new launches in US impacting growth

Granules India Q1 net profit up 19% at Rs 27 crore

23 Jul 2015

Total income from operations for the quarter under review grew 11.23% annually

Lupin buys US generics firm Gavis for $880 million

23 Jul 2015

Lupin Ltd , India's fourth-largest drugmaker by sales, said it had agreed to buy privately-held generics company Gavis for $880 million to ...

Lupin dips as Q1 results miss Street estimates

23 Jul 2015

The stock dipped 6% at Rs 1,714 after the company reported a 16% Y-o-Y drop in consolidated net profit at Rs 525 crore in the June quarter.

Quick Links


Back to Top